W. Va. Code R. § 69-7-29 - Orientation

29.1. Every person admitted to an opioid treatment program shall receive program orientation. The orientation shall be made verbally at the earliest opportunity at which the patient is stable and capable of understanding and retaining the information presented. Information provided in the orientation shall be given to the patient at the time the decision is made to admit the patient, regardless of his or her condition.

29.2. Orientation shall include the following:

29.2.a. An explanation of the rights and responsibilities of the patient.

29.2.b. An explanation of the patient's right to file a grievance and applicable appeal procedures.

29.2.c. An explanation of the services and activities provided by the opioid treatment program, including:

29.2.c.1. Expectations and rules;

29.2.c.2. Hours of operation;

29.2.c.3. Access to after-hour services;

29.2.c.4. Confidentiality policy;

29.2.c.5. Toxicological screening and random testing policies;

29.2.c.6. Sanctions, restrictions and other penalties;

29.2.c.7. Interventions;

29.2.c.8. Incentives; and

29.2.c.9. Various discharge criteria.

29.2.d. An explanation about obtaining reports from the Controlled Substances Monitoring Program database; how the reports are used to treat and monitor the patient and the requirement that the reports be maintained in the patient files.

29.2.e. An explanation of any and all financial obligations of the patient; all fees charged by the opioid treatment program; and any financial arrangements for services provided by the opioid treatment program.

29.2.f. Familiarization with the opioid treatment programs facility and premises.

29.2.g. A description of the opioid treatment program's policies regarding:

29.2.g.1. Use of alcohol on or prior to entering the premises;

29.2.g.2. Smoking;

29.2.g.3. Illicit or licit drugs brought into the program; and

29.2.g.4. Weapons brought into the program.

29.2.h. Identification of the counselor assigned to the patient and contact information for that counselor.

29.2.i. A copy of the opioid treatment program rules identifying the following:

29.2.i.1. Any restrictions the program may place on the patient;

29.2.i.2. Events, behaviors, or attitudes that may lead to the loss of rights or privileges for the patient; and

29.2.i.3. Means by which the patient may regain rights or privileges that have been restricted.

29.2.j. An explanation of the purpose and process of the initial and subsequent medical and psychological assessments; and

29.2.k. A description of how the individualized treatment plan of care will be developed and the patient's expected participation in the plan of care.

29.2.l. An explanation of alternative methods that are available for treatment of opioid addiction, whether offered by the program or not, and the potential benefits, risks and costs of each treatment.

29.3. Upon admission, each patient shall receive the following written information:

29.3.a. Signs and symptoms of overdose and when, where and how to seek emergency assistance;

29.3.b. A formal agreement of informed consent to be signed by the patient and a copy retained by him or her;

29.3.c. Patient's rights;

29.3.d. Confidentiality policies; and

29.3.e. The program's processes for dispensing medication.

29.3.f. Information on alternative methods available for treatment of opioid addiction and the potential benefits, risks and costs of each treatment. The state authority is responsible for providing informational materials to be used in discussing alternative treatments.

29.4. As soon as the individual is stable and capable of understanding, the patient shall receive group or individual education on the following:

29.4.a. Medication administration, including methods of dispensing and dosage restrictions;

29.4.b. The nature of addictive disorders including the great likelihood that addiction is a relapsing disease and is likely to have grave medical and social consequences if not treated on an ongoing basis;

29.4.c. The anticipated benefits of treatment;

29.4.d. The nature of the recovery process;

29.4.e. HIV spectrum and other infectious diseases;

29.4.f. Potential drug interactions;

29.4.g. Self-help groups, if any are available;

29.4.h. Medical issues related to detoxification from opioid treatment medications;

29.4.i. The special risk of withdrawal from methadone and detoxification to pregnant women and the fetus (as appropriate);

29.4.j. Characteristics of the medications administered and/or prescribed by the program;

29.4.k. Drug safety issues;

29.4.l. Dispensing procedures; and

29.4.m. Side effects of medications administered or prescribed by the program.

29.5. Documentation that the patient has completed the orientation training shall be completed and signed by the program physician and the patient and maintained in the patient's chart and individualized treatment plan of care.

Notes

W. Va. Code R. § 69-7-29